Originally published In Press as doi:10.1074/jbc.M108462200 on January 30, 2002
J. Biol. Chem., Vol. 277, Issue 14, 11746-11755, April 5, 2002
Mitochondrial Metabolism Sets the Maximal Limit of
Fuel-stimulated Insulin Secretion in a Model Pancreatic Beta Cell
A SURVEY OF FOUR FUEL SECRETAGOGUES*
Peter A.
Antinozzi
§,
Hisamitsu
Ishihara
,
Christopher B.
Newgard¶, and
Claes B.
Wollheim
From the
Division of Clinical Biochemistry and
Experimental Diabetology, Department of Internal Medicine, University
Medical Center, CH-1211 Geneva 4, Switzerland and from the
¶ Touchstone Center for Diabetes Research, Departments of
Biochemistry and Internal Medicine, University of Texas
Southwestern Medical Center, Dallas, Texas 75390
Received for publication, September 4, 2001, and in revised form, December 27, 2001
 |
ABSTRACT |
The precise metabolic steps that couple glucose
catabolism to insulin secretion in the pancreatic beta cell are
incompletely understood. ATP generated from glycolytic metabolism in
the cytosol, from mitochondrial metabolism, and/or from the hydrogen
shuttles operating between cytosolic and mitochondrial compartments has been implicated as an important coupling factor. To identify the importance of each of these metabolic pathways, we have compared the
fates of four fuel secretagogues (glucose, pyruvate, dihydroxyacetone, and glycerol) in the INS1-E beta cell line. Two of these fuels, dihydroxyacetone and glycerol, are normally ineffective as
secretagogues but are enabled by adenovirus-mediated expression of
glycerol kinase. Comparison of these two particular fuels allows the
effect of redox state on insulin secretion to be evaluated since the phosphorylated products dihydroxyacetone phosphate and glycerol phosphate lie on opposite sides of the NADH-consuming glycerophosphate dehydrogenase reaction. Based upon measurements of glycolytic metabolites, mitochondrial oxidation, mitochondrial matrix calcium, and
mitochondrial membrane potential, we find that insulin secretion most
tightly correlates with mitochondrial metabolism for each of the four
fuels. In the case of glucose stimulation, the high control strength of
glucose phosphorylation sets the pace of glucose metabolism and thus
the rate of insulin secretion. However, bypassing this reaction with
pyruvate, dihydroxyacetone, or glycerol uncovers constraints imposed by
mitochondrial metabolism, each of which attains a similar maximal
limit of insulin secretion. More specifically, we found that the
hyperpolarization of the mitochondrial membrane, related to the proton
export from the mitochondrial matrix, correlates well with insulin
secretion. Based on these findings, we propose that fuel-stimulated
secretion is in fact limited by the inherent thermodynamic
constraints of proton gradient formation.
 |
INTRODUCTION |
The pancreatic islet beta cell secretes insulin in
response to several metabolic fuels, and this occurs via the metabolism of the stimulatory agents rather than their interaction with a receptor (summarized by Newgard and McGarry, see Ref. 1). Fuel secretagogues such as glucose are metabolized to generate ATP. The
increased ATP:ADP ratio inhibits ATP-sensitive K+
(K
) channels, which in turn causes depolarization of the plasma membrane, Ca2+ entry
through voltage-gated L-type Ca2+ channels, and activation
of exocytosis of insulin-containing secretory granules. The requirement
for fuel metabolism and nucleotide generation is also observed in the
presence of depolarizing concentrations of K+ combined with
diazoxide, which prevents K
channel
closure, and this has been termed the
K
channel-independent pathway of
glucose-stimulated insulin secretion (GSIS)1 (2-4). Whereas the
effects of K
channel inhibition and
calcium entry on insulin release are widely acknowledged, the source of
ATP that regulates the ion channels and the potential involvement of
other factors remain as open questions.
ATP is generated by both cytosolic and mitochondrial reactions.
Cytosolic ATP production comes from two reactions in the distal portion
of glycolysis, 3-phosphoglycerate kinase and pyruvate kinase.
Mitochondrial ATP is derived in part from hydrogen shuttles, primarily
the malate-aspartate (5-7) and glycerophosphate shuttles, (8-10)
which are very active in islet beta cells. Finally, a major portion of
ATP production comes from mitochondrial oxidation of glucose-derived
pyruvate. There is evidence to support an important role of each of
these discrete sources of ATP in the regulation of insulin secretion.
Evidence for a role of glycolysis-derived ATP comes from studies in
which inhibitors of glycolytic but not mitochondrial ATP-producing
reactions inhibited GSIS (11). Evidence for an important role of
hydrogen shuttles comes from studies showing near complete impairment
of GSIS in islets from mice lacking mitochondrial glycerol phosphate
dehydrogenase and incubated with aminooxyacetate to inhibit
their malate-aspartate shuttle activity (12, 13). Finally, GSIS is
impaired by inhibitors of oxidative phosphorylation (14) and
mitochondrial uncouplers (15) and in cells with impaired mitochondrial
function (16-19), supporting a role of ATP derived from fuel oxidation.
Stimulation of islets with fuels other than glucose suggests that
important coupling factors are generated via cytosolic metabolism. The
so-called "pyruvate paradox" is one such example because the mitochondrial fuel pyruvate is readily oxidized in islet preparations but does not elicit insulin secretion (20, 21). In contrast, glyceraldehyde, which functions both as a cytosolic and mitochondrial fuel, is a potent secretagogue (22-24). In another study, the
glycolytic intermediate glyceraldehyde phosphate (GAP) stimulated
insulin release from pancreatic islets, and this effect was not
impaired by mitochondrial inhibitors (15). However, glyceraldehyde can be converted to the non-metabolizable intermediate
glycerate-1-phosphate while still generating NADH (25) and can cause
acidification of the cytosol (26-28), making it difficult to fully
interpret experiments with this secretagogue. Acidification has also
been observed in studies with another widely used metabolite analog, methyl pyruvate (29, 30). Since acidification alone can stimulate ATP
generation in isolated mitochondria, the use of such compounds to
dissect the role of cytosolic and mitochondrial signal generation could
be misleading.
To clarify the roles of cytosolic and mitochondrial metabolism of
carbohydrate fuels in the regulation of insulin secretion, we developed
a novel strategy to provide metabolic input at the point of triose
metabolism (31). Due to low glycerol phosphorylating activity,
pancreatic beta cells do not metabolize glycerol efficiently enough to
elicit insulin secretion. However, with adenovirus-mediated expression
of glycerol kinase, glycerol is efficiently metabolized, which allows
the stimulation of insulin secretion (31) and proinsulin biosynthesis
from a glycerol challenge (32). The advantage of this strategy is that
the nonspecific effects of glycerol (i.e. side reactions, pH
changes) are controlled by the inclusion of cells not engineered for
glycerol kinase expression. Furthermore, as shown in the current study,
glycerol kinase expression activates the conversion of dihydroxyacetone
(DHA) to dihyroxyacetone phosphate (DHAP), thereby allowing DHA to
become an insulin secretagogue. In the current study, we have measured
the metabolic fates of four distinct carbohydrate fuels, glucose,
pyruvate, glycerol, and DHA, in cells enabled for triose-stimulated
insulin secretion by glycerol kinase expression. Neither large
increases of glycolytic intermediates nor marked changes in the redox
state influenced insulin secretion. Stimulation of secretion by these
fuels most closely correlated to changes in the mitochondrial membrane
potential, suggesting that the generation of the mitochondrial proton
gradient, ATP, and other mitochondrially derived metabolites are
essential signals for insulin secretion.
 |
MATERIALS AND METHODS |
Insulin Secretion and Metabolite Measurements--
INS1-E cells
were cultured as described by Asfari et al. (33) and seeded
at a density of 1.5 × 106 cells/well in a 6-well
tissue culture plate (Falcon). One day prior to the experiment, the
cells were transduced with Ad-GlpK virus (see Ref. 31 for details) and
cultured in RPMI 1640 containing 5 mM glucose. Cells were
washed 3 times with modified Krebs-Ringer bicarbonate buffer (KRBH)
containing (in mM): 135 NaCl, 3.6 KCl, 10 HEPES (pH 7.4), 5 NaHCO3, 0.5 NaH2PO4, 0.5 MgCl, and
1.5 CaCl2 and preincubated for 30 min in KRBH with 2.5 mM glucose. Cells were washed an additional two times and
incubated with KRBH supplemented with the appropriate secretagogue.
After 15 min of incubation, medium was collected for insulin
radioimmunoassay, and cells were quickly frozen in liquid nitrogen with
the addition of 0.6 M perchloric acid. Extracts were
collected on ice, sonicated, and centrifuged. The supernatant was
neutralized with K2CO3, and DHAP, GAP, FBP, pyruvate, lactate, and glycerol phosphate were measured by the methods
compiled by Bergenmeyer (34).
Substrate Oxidation--
Oxidation assays were performed
essentially as described by Antinozzi et al. (35). For each
data point, ~1 × 106 cells were resuspended in KRBH
and dispensed into a center well placed within a scintillation vial.
Radiolabeled substrate (~500,000 cpm [2-14C]DHA
or [2-14C]glycerol) was diluted with unlabeled substrate
and added to the cell suspension, and the vial was sealed with a rubber
septum. After 1 h, 100 µl of 7% perchloric acid was injected
into the center well, and 300 µl of benzethonium hydroxide was
injected at the bottom of the vial. Following 5 h at room
temperature, the center well was removed, liquid scintillation mixture
was added to the vial, and the amount of
[14CO2] generated was counted.
Glycerol Kinase Activity--
Glycerol kinase activity was
measured by an adaptation of the spectrophotometric method of Wieland
and Suyter (36). The phosphorylation of glycerol was coupled to the
reduction of NAD by the action of L-
-glycerophosphate
dehydrogenase. The reaction mixture contained 10 mM
glycerol, 20 mM MgCl2, 20 mM ATP,
and 1.6 mM NAD+ prepared in a
hydrazine/glycine/EDTA (400 mM/1 M/5
mM) buffer at pH 9.5. Six units of
L-
-glycerophosphate dehydrogenase (Sigma) were added,
and a baseline was established. The activity measurement was initiated
with the addition of 50 µg of cell extract, and NADH absorbance was
followed at 339 nm for 15 min. Activity was calculated from the slope
of an absorbance versus time plot.
Mitochondrial Membrane Potential--
INS1-E cells (3 × 106) were centrifuged and resuspended in 2 ml of KRBH with
2.5 mM glucose and 10 µg/ml rhodamine-123 (Molecular Probes) for 10 min. Cells were centrifuged and resuspended in 2 ml of
KRBH and transferred to a glass cuvette. After stabilization of the
fluorescence signal for 15 min, secretagogues were sequentially added
followed by a final addition of 1 µM FCCP. Changes in
rhodamine-123 fluorescence were recorded every 3 s with the
excitation wavelength set at 490 nm and emission at 538 nm with
a 515-nm cutoff filter in a LS-50B PerkinElmer fluorimeter. Traces were
normalized by setting the fluorescence at the initial 15 min
stabilization period as 0% and maximal hyperpolarization as
100%.
Mitochondrial Matrix Calcium and Perifusion--
INS1-E cells
(800 × 105) were seeded on 15-mm A431 extracellular
matrix-coated plastic coverslips. Cells were treated with Ad-GlpK (31) and Ad-CAG-mAeq adenoviruses. The Ad-CAG-mAeq adenovirus was prepared by the method described previously by Miyake et
al. (37). Briefly, an EcoRI fragment that contains the
entire aequorin coding sequence fused to the mitochondrial
matrix-targeting sequence from human cytochrome c
oxidase subunit VIII (38) was subcloned into a shuttle vector pAdCAG.
The resulting vector pAdCAGmAeq and EcoT22I-digested adenovirus type 5 DNA-terminal protein complex was co-transfected into HEK293 cells.
Correctly recombined viral clones were selected by restriction enzyme
digestions and purified by CsCl gradient centrifugation. Twenty h after
viral treatment, cells were loaded with coelenterazine (2.5 µM) in (glucose, glutamine, fetal calf serum)-free RPMI
1640 for 1 h and then placed in a hermetically sealed,
thermostatted chamber at 37 °C and perifused for 15 min with 2.5 mM glucose KRBH prior to the start of the experiment. The
number of emitted photons was measured every second, and effluent
fractions were collected for insulin radioimmunoassay at 1-min
intervals. Mitochondrial calcium was calculated from the raw photon
count data using software available online
(www.clocs.com/aequorin/).
 |
RESULTS |
Glycerol-stimulated Insulin Secretion from Ad-GlpK-treated INS1-E
Cells--
The current studies were conducted with the INS1-E cell
line, which was clonally selected from the parental INS1 cell line (33)
based on its improved insulin secretion profile (39, 40). Static
secretion experiments from the INS1-E cells could be conducted over
15-min intervals as opposed to 2-3 h intervals with parental INS-1
cells (31), allowing a more relevant correlation of metabolite levels
to secretion.
INS1-E cells engineered for glycerol kinase expression by treatment
with the Ad-GlpK adenovirus secrete insulin in a glucose dose-dependent manner with maximal secretion occurring at
10 mM glucose (Fig.
1A). Glycerol kinase
expression does not affect the glucose dose-response curve since
untreated INS1-E cells have a similar profile (41). Ad-GlpK-treated
cells are more sensitive to glycerol than glucose such that similar
amounts of insulin are secreted in response to 16 mM
glucose or 2 mM glycerol (Fig. 1B). In addition
to glycerol, Escherichia coli glycerol kinase (as expressed
with the Ad-GlpK virus) phosphorylates DHA to yield the glycolytic
intermediate DHAP. DHA is as potent as glycerol in Ad-GlpK-treated
cells with maximal stimulation of insulin secretion occurring at 2 mM DHA (Fig. 1C). Neither glycerol nor DHA
stimulates insulin secretion in control INS1-E cells lacking glycerol
kinase overexpression, assuring that phosphorylation and subsequent
metabolism of these fuels is required for stimulation of insulin
secretion (Fig. 1, B and C). The lower threshold
for stimulation of insulin secretion seen with glycerol and DHA as
compared with glucose is consistent with the high affinity of glycerol
kinase for the triose substrates (Km = 1.3 µM for glycerol and 500 µM for DHA) (42).
In contrast, glucose entry into triose metabolism is restricted by the
low affinity glucokinase (S0.5 ~8 mM) (43). The similar threshold for stimulation of insulin secretion by glycerol
as compared with DHA may seem surprising in light of the higher
Km of glycerol kinase for the DHA. However, to enter
glycolysis, glycerol phosphate must first be converted to DHAP by the
cytosolic or the Ca2+-sensitive mitochondrial
glycerophosphate dehydrogenases, which have
Km values of 300 µM (44) and 1-9
mM (45, 46), respectively, for glycerol phosphate, whereas
DHAP bypasses this reaction to enter glycolysis.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
Stimulated insulin secretion with four fuel
secretagogues. Insulin release from ~1.5 × 106
INS1-E cells was measured after a 15-min static incubation with the
given concentration of each secretagogue. INS1-E cells were treated
with (solid bar) or without (hatched bar) Ad-GlpK
adenovirus. Glycerol kinase activity for these experiments was
44.4 ± 3.8 and 0.7 ± 0.2 nmol/mg protein/min for
Ad-GlpK-treated and untreated INS1-E cells, respectively
(n = 8). A, dose-response curve for glucose.
Note that glucose reaches maximal stimulation at 10 mM and
that Ad-GlpK treatment does not affect the 16 mM glucose
response. B, dose-response curve for glycerol. Glycerol
stimulation attains maximal secretory potency at 2 mM,
which is comparable with a 16 mM glucose stimulus. Note
that untreated INS1-E cells are not glycerol-responsive. C,
dose-response curve for DHA. Stimulation of insulin secretion with DHA
reaches a maximum at 2 mM, and a similar response
is achieved with 16 mM glucose. DHA (2 mM) is
ineffective on untreated INS1-E cells. D, dose-response
curve for pyruvate. Pyruvate stimulation of Ad-GlpK-treated INS1-E
cells reaches a maximal limit at 1-2 mM. This stimulation
is comparable with a 16 mM glucose challenge, and Ad-GlpK
treatment does not affect the magnitude of the pyruvate response.
E, insulin secretion with secretagogue combinations
and PMA. INS1-E cells treated with Ad-GlpK adenovirus were stimulated
with combinations of 16 mM glucose (Glc) and 2 mM pyruvate (Pyr), 2 mM DHA, 2 mM glycerol (Gly), or 50 nM PMA.
Note that none of the fuel secretagogue combinations could surpass the
insulin release of 16 mM glucose alone and the potentiator,
PMA, could exceed this limitation by 485%. Each bar
represents the mean and S.E. of 3-5 experiments performed in 2-6
replicates. Panels B-D include a 16 mM glucose
control performed on the same cell preparations.
|
|
A fourth fuel secretagogue, pyruvate, was utilized to isolate those
coupling factors that are derived from mitochondrial metabolism. Pyruvate has the lowest threshold concentration for stimulation of
insulin secretion among the four fuels studied with half-maximal stimulation occurring at 0.5 mM (Fig. 1D). Note
that all four secretagogues caused a similar rate of insulin secretion
at their maximally effective concentrations, and this ceiling
could not be exceeded by combinations of the four fuels (Fig.
1E). These results suggest that a common limit in metabolism
is attained with each of the four fuel stimuli, and this in turn
restricts the metabolic signaling of insulin exocytosis. An alternative possibility is that that the ceiling of insulin release is set by steps
of exocytosis or insulin biosynthesis. This possibility can readily be
ruled out by known potentiators of fuel-stimulated insulin release. As
shown in Fig. 1E, the inclusion of the phorbol ester, PMA,
with 16 mM glucose can surpass the secretory limit imposed
by fuel stimuli alone by 485%.
Comparison of Glycolytic Metabolite Levels for Glucose, Glycerol,
DHA, and Pyruvate--
Following 15 min of stimulation with the
various fuels and measurement of insulin secretion as shown in Fig. 1,
the cells were collected for measurement of the levels of various
glycolytic intermediates. Triose phosphate levels (DHAP + GAP)
increased 3.3-fold as glucose was raised from 2 to 16 mM
(Fig. 2B). In comparison, at
concentrations with a secretory effect equivalent to the
maximally effective doses of glucose, DHA and glycerol caused triose
phosphate levels to rise to 3.9 and 5.0 times above those observed at
16 mM glucose, respectively. Predictably, as pancreatic
beta cells lack phoshoenolpyruvate carboxykinase (47), 2 mM
pyruvate did not increase triose phosphate levels while stimulating
insulin secretion to the same extent as the other fuels. It has been
suggested that glyceraldehyde phosphate dehydrogenase becomes
rate-limiting as substrate flux into the distal portion of glycolysis
is increased in beta cells and insulinoma cell lines, which is
possibly related to the limited capacity for NAD+
regeneration (48, 49). This may in part explain the higher levels of
triose phosphates caused by incubation of Ad-GlpK-treated cells with
DHA or glycerol relative to glucose. To address this point, fructose
1,6-bisphosphate (FBP) levels were measured as they would be predicted
to rise with an accumulation of DHAP and GAP. FBP levels increased
15-fold as glucose was raised from 2 to 16 mM (Fig.
2C). However, incubation of Ad-GlpK-treated cells with 2 mM DHA or 2 mM glycerol caused FBP
levels to rise 7- and 14-fold higher, respectively, than with 16 mM glucose. The greater accumulation of FBP in the presence
of glycerol may be due to the competition for NAD+ between
glycerol phosphate dehydrogenase and glyceraldehyde phosphate dehydrogenase. FBP levels did not change in Ad-GlpK-treated cells incubated with 2 mM pyruvate or in untreated cells
incubated with 2 mM glycerol or 2 mM DHA
relative to basal levels in the same cells incubated with 2 mM glucose.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 2.
Glycolytic intermediate measurements.
Neutralized perchloric acid cellular extracts were prepared from the
same samples obtained from the secretion experiments in Fig. 1 and
assayed for the following glycolytic intermediates. A,
fuel-stimulated insulin secretion. This is a summary of
selected insulin secretion results from Fig. 1. Note that insulin
release stimulated by 16 mM glucose (Glc), 2 mM DHA, 2 mM glycerol (Gly), and 1 mM pyruvate (Pyr) is similar despite marked
differences in glycolytic intermediate profiles. B, triose
phosphates. The combined levels of DHAP and GAP were assayed from
cellular extracts. Note that the triose phosphates measured from DHA
and glycerol-stimulated Ad-GlpK-treated INS1-E cells greatly exceed
those levels obtained in cells receiving a 16 mM glucose
stimulus. Pyruvate (1 mM) in Ad-GlpK-treated cells or DHA
and glycerol (2 mM) in untreated INS1-E cells do not raise
triose phosphate levels above those observed with 2 mM
glucose. C, fructose 1,6-bisphosphate. FBP levels were
drastically elevated by glycerol and DHA (2 mM) relative to
a 16 mM glucose stimulation in Ad-GlpK-treated cells.
Glycerol increased FBP levels more than DHA, likely due to the
exhaustion of cytosolic NAD+ and impairment of GAP disposal
via glyceraldehyde phosphate dehydrogenase. Pyruvate (1 mM)
in Ad-GlpK-treated cells and DHA and glycerol did not elevate FBP
levels above those observed with 2 mM glucose.
D, pyruvate. A stimulation of both 2 mM trioses
and 1 mM pyruvate led to an approximate doubling of
pyruvate levels relative to 16 mM glucose after a 15-min
challenge. In untreated INS1-E cells, DHA and glycerol did not elevate
pyruvate levels above levels observed with 2 mM glucose.
E, redox ratio. The cytosolic redox state was estimated by
splitting the extract into two equal parts and measuring glycerol
phosphate and DHAP in each half of the extract. Glycerol phosphate
levels were below detection (BD) of the assay for 2 mM glucose, 1 mM pyruvate, and in the untreated
INS1-E cells challenged with 2 mM DHA and 2 mM
glycerol. Note that 2 mM DHA decreases and 2 mM
glycerol increases this ratio relative to a 16 mM glucose
challenge without an effect on insulin secretion from each of these
three stimuli. Each bar represents the mean and S.E. of 6-8
experiments.
|
|
Comparison of Pyruvate Levels in Ad-GlpK-treated Cells Incubated
with Glucose, Glycerol, DHA, or Pyruvate--
We next measured
pyruvate levels in Ad-GlpK-treated cells incubated with each of the
four fuels. Stimulation with 16 mM glucose increased
pyruvate levels 4.6-fold over levels obtained at 2 mM glucose (Fig. 2D). The increase in pyruvate production from
2 mM glycerol and 2 mM DHA was significantly
higher than with 16 mM glucose, reaching levels that were
12- and 11-fold higher than 2 mM glucose. This observation
further demonstrates that triose substrates enter the distal portion of
glycolysis more efficiently than glucose, which is constrained
by the high Km value of glucokinase. In our prior
study, lactate (measured in the secretion medium) was 2-3-fold higher
in Ad-GlpK-treated cells incubated with glycerol relative to glucose
(31). This enhanced capacity for lactate production from glycerol was
hypothesized to result from high NADH levels caused by flux through
cytosolic glycerol phosphate dehydrogenase. In the current study,
intracellular lactate levels were measured, and we confirm an increased
capacity of lactate production from glycerol as compared with glucose
(84.4 ± 11.4 versus 51.8 ± 12.0 nmol/mg
protein/15 min) at 2 mM glycerol and 16 mM
glucose, respectively (n = 3) Interestingly, 2 mM DHA also causes a large increase in lactate levels
(120 ± 20.2 nmol/mg protein/15 min) despite the fact that DHA
bypasses NADH generation at the glycerophosphate dehydrogenase step.
These results suggest that the large increment in lactate output that
occurs in cells incubated with either triose fuel is probably a direct
consequence of elevated pyruvate levels rather than a function of redox conditions.
Comparision of Redox Conditions in Ad-GlpK-treated Cells Incubated
with Glucose, Glycerol, DHA, or Pyruvate--
In INS1-E cells with
glycerol kinase expression, both DHA and glycerol stimulate insulin
secretion even though their phosphorylated products lie on opposite
sides of the glycerol phosphate dehydrogenase reaction. Measurements of
certain redox pairs (such as glycerol phosphate:DHAP) are a reflection
of the cellular redox state (50). We therefore investigated the role of
redox status by measurement of the relative levels of glycerol
phosphate and DHAP in cells incubated with the various fuels. The redox
ratio (glycerol phosphate:DHAP) in cells stimulated with 16 mM glucose for 15 min was 0.64 ± 0.31 (Fig.
2E). Following treatment with 2 mM DHA, the
redox ratio was lower (0.23 ± 0.21), whereas treatment with 2 mM glycerol caused it to be 5.3 times higher (3.4 ± 1.0) than observed with 16 mM glucose. Despite the extreme
shift in redox state that it causes, glycerol is as effective a
secretagogue as glucose and DHA (Fig. 2A), strongly
suggesting that cytosolic redox conditions are not a key factor in
stimulation of insulin secretion by carbohydrate fuels. Note that due
to the low levels of glycerol phosphate in INS1-E cells treated with 2 mM glucose or 1 mM pyruvate, the ratios under
these conditions could not be accurately determined.
Mitochondrial Oxidation of Glycerol and DHA--
To this point,
increased pyruvate levels is the common denominator for all of the
tested fuel secretagogues. Due to the lack of phoshoenolpyruvate
carboxykinase (23) activity in beta cells, this suggests that the
potency of a given fuel is determined by pyruvate entry into the
mitochondria and its subsequent metabolism. The fact that the triose
secretagogues can increase pyruvate and lactate levels beyond those
observed from a glucose stimulus further suggests that mitochondrial
metabolism limits the disposal of pyruvate. To substantiate this, we
measured oxidation of 2-14C-labeled glycerol or DHA in
Ad-GlpK-treated INS1-E cells. The 14C label at
carbon 2 is lost to CO2 either at the
-ketoglutarate dehydrogenase step of the tricarboxylic acid cycle when pyruvate enters
via pyruvate dehydrogenase or at either the
-ketoglutarate or
isocitrate dehydrogenase reactions when pyruvate enters the tricarboxylic acid cycle via pyruvate carboxylase. The
2-14C-labeled substrates were selected over the
U-14C-labeled substrates used in our previous study (31) to
allow a more precise determination of the flux through these two
tricarboxylic acid cycle dehydrogenases. As shown in Fig.
3, oxidation of
[2-14C]glycerol or DHA in Ad-GlpK-treated cells increased
in a dose-dependent manner, reaching a maximum for both
fuels at a concentration of 2 mM, which is in close
correlation with insulin secretion. 2-14C oxidation for
both fuels was blocked by 50 nM rotenone (an
inhibitor of NADH-coenzyme Q oxidoreductase of the electron transport
chain). [2-14C]Glycerol oxidation was negligible in
untreated INS1 cells, whereas oxidation was measurable at 2 mM DHA, albeit not at a rate sufficient to stimulate
insulin secretion.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Triose and pyruvate oxidation.
A, triose oxidation. CO2 generation from
[2-14C]glycerol or [2-14C]DHA oxidation at
the given substrate concentrations was measured after 1 h from
INS1-E cells treated with (solid bars) or without
(hatched bars) Ad-GlpK adenovirus. Ad-GlpK adenovirus
enables efficient oxidation of DHA and glycerol relative to untreated
INS1-E cells at all tested concentrations. Although significantly
higher triose oxidation was observed at 0.5 mM in
Ad-GlpK-treated versus untreated INS1-E cells, this increase
was not accompanied by a stimulation of insulin secretion (see Fig. 1).
Note that in untreated cells, there is a general trend of a more
efficient oxidation of DHA as compared with glycerol. Rotenone (50 nM) blocked oxidation of both DHA and glycerol (at 2 mM) by 80% in Ad-GlpK-treated INS1-E cells. Each
bar represents the mean and S.E. of 3-7 experiments
performed in triplicate. ND, not determined. B,
pyruvate oxidation. CO2 generation from
[1-14C]pyruvate oxidation at the given concentrations was
measured after 1 h from INS1-E cells. Each bar
represents the mean and S.E. of 3 experiments performed in
triplicate.
|
|
Since each of the fuel stimuli used in this study generates pyruvate,
it is possible that mitochondrial transport and metabolism of pyruvate
is the common constraint of metabolism. To address this possibility, we
measured [1-14C]pyruvate oxidation at various pyruvate
concentrations. The 1-14C label is removed as
CO2 as pyruvate dehydrogenase catalyzes the decarboxylation
of pyruvate to acetyl-CoA. Pyruvate concentrations above 1 mM neither increase oxidation (Fig. 3B) nor
enhance insulin secretion (Fig. 1D). Pyruvate dehydrogenase
does not likely have excess capacity in intact cells since the pyruvate
concentration to achieve maximal [1-14C]pyruvate
oxidation was not greater than the concentration to maximally stimulate
insulin secretion.
Hyperpolarization of Mitochondrial Membrane Potential by Glycerol,
DHA, Pyruvate, and Glucose--
To evaluate possible metabolic
constraints imposed by the electron transport chain and the generation
of a proton gradient, mitochondrial membrane potential was measured
using the fluorescent dye rhodamine-123. Fuel oxidation via the
tricarboxylic acid cycle supplies NADH and FADH2 to power
the formation of a proton gradient across the inner mitochondrial
membrane. This proton gradient in turn provides the energy to drive ATP
formation. In concert with the formation of the gradient, the inner
mitochondrial membrane becomes hyperpolarized due to the extrusion of
positively charged protons. As observed with substrate oxidation, 2 mM glycerol had no effect on mitochondrial activation in
untreated INS1-E cells (Fig.
4A), whereas in the same
cells, 16 mM glucose caused a clear hyperpolarization and 2 mM DHA was about 15% as effective as glucose. In
Ad-GlpK-treated INS1-E cells, an initial stimulation with either 2 mM glycerol (Fig. 4A) or 2 mM DHA
(Fig. 4B) hyperpolarized the mitochondrial membrane to a
point at which subsequent addition of 16 mM glucose had no
further effect. This suggests that 2 mM triose is
sufficient to maximally stimulate the respiratory chain. This tight
relationship of mitochondrial membrane potential and insulin secretion
is further supported by dose-response studies performed with all four
fuels, wherein maximal activation of mitochondrial membrane potential
(Fig. 4, C and D) and maximal activation of insulin secretion (Fig. 1) were correlated in each case.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 4.
Mitochondrial membrane potential.
Fuel-mediated changes in mitochondrial membrane potential were
estimated by rhodamine-123 fluorescence. A,
glycerol-stimulated hyperpolarization. At 15 min, 2 mM
glycerol was added followed by 16 mM glucose at 20 min.
Note that glycerol hyperpolarizes the mitochondrial membrane only in
Ad-GlpK-treated INS1-E cells and that 16 mM glucose does
not markedly enhance this effect further. B, DHA-stimulated
hyperpolarization. At 15 min, 2 mM DHA was added followed
by 16 mM glucose at 20 min. Note that DHA slightly
hyperpolarizes the mitochondrial membrane in untreated INS1-E cells and
hyperpolarizes Ad-GlpK-treated INS1-E cells to the same extent as 16 mM glucose. C, glucose-stimulated
hyperpolarization. At 5 min intervals, additions of glucose in 2 mM increments were added to the cell suspension until a
concentration of 16 mM was reached. Complete
hyperpolarization occurs at 10 mM glucose. D,
dose-dependence of pyruvate, glycerol, and DHA. , pyruvate; ,
glycerol; , DHA. Sequential additions of each fuel were added until
a maximal hyperpolarization was obtained. Once this maximum
hyperpolarization was reached, no combination of any of the fuel
secretagogues could surpass this limit (data not shown). Note the left
shift in the concentration dependence of pyruvate as compared with the
triose-secretagogues. Each data point represents the mean and S.E. of
3-4 determinations at the given concentration. E,
mono-methyl succinate (MMS)-stimulated hyperpolarization. At
15 and 20 min, either 5 mM mono-methyl succinate was
followed by 16 mM glucose or 16 mM glucose was
followed by 5 mM MMS. Note that MMS could maximally attain
only 50% of a glucose stimulus and that when combined, these fuels
cannot exceed a 16 mM glucose hyperpolarization. For
panels A-C and E, each trace represents the mean
and S.E. of 3-4 experiments. At the end of each trace, 1 µM FCCP was added to uncouple the mitochondria and
plateaued at similar levels for each trace (not shown).
|
|
Succinate bypasses NADH-oxidoreductase (site I) and provides electrons
to the electron transport chain via the FAD-linked succinate
dehydrogenase (site II). Methyl succinate, a plasma membrane-permeant
source of succinate, hyperpolarizes the mitochondrial membrane in a
dose-dependent fashion (data not shown), although the
maximal effect obtained (at 5 mM) is only 50% of a 16 mM glucose stimulation (Fig. 4E). Methyl
succinate (5 mM) does not cause a further hyperpolarization
when following a glucose (Fig. 4E), triose, or pyruvate
stimulus (data not shown). Again, this suggests that the maximal proton
gradient attained with each fuel cannot be surpassed even when
providing electron input beyond NADH-oxidoreductase.
Time Course of Insulin Secretion and Mitochondrial
Ca2+--
The foregoing studies were largely carried out
under static incubation conditions. To assess mitochondrial activation
in perifused INS1-E cells in real time, cells were treated with two
adenoviruses, one encoding a mitochondrial targeted aequorin
(Ad-CAG-mAeq), a luminescent Ca2+ sensor, and the Ad-GlpK
virus. This system allows simultaneous evaluation of mitochondrial
matrix Ca2+ (which reflects the activation of mitochondria)
and insulin release in response to the various fuels (51). Cells
prepared in this manner were perifused without glucose for 15 min prior
to a 10-min stimulation with DHA. A sharp increase in mitochondrial
Ca2+ occurred within 30-60 s of DHA application, followed
30-60 s later by a surge in insulin secretion (Fig.
5A). Switching back to
perifusion medium without DHA returned both mitochondrial calcium and
insulin output to basal levels. After 30 min, a restimulation with 16 mM glucose caused increases in both mitochondrial calcium and insulin secretion that were almost identical in temporal sequence and magnitude as observed with 2 mM DHA. Similar results
were obtained with 2 mM glycerol. (Fig. 5B).
Neither DHA nor glycerol elevated mitochondrial Ca2+ or
stimulated insulin secretion in INS1-E cells treated only with the
Ad-CAG-mAeq adenovirus (data not shown). To verify that glycerol-stimulated insulin secretion requires mitochondrial
respiration, 50 nM rotenone was shown to suppress both the
mitochondrial Ca2+ signal and insulin secretion induced by
2 mM glycerol (Fig. 5C).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
Mitochondrial calcium and insulin
secretion. Simultaneously, emitted photons were measured (1-s
intervals) and perifusate was collected (1-min intervals) from INS1-E
cells perifused with several media changes. The mitochondrial
Ca2+ levels were calculated from the photon emission of
coelenterazine-loaded mAeq expressing INS1-E cells. Insulin was
measured in the perifusate by radioimmunoassay. A, DHA
stimulation. Following a 15-min perifusion of KRBH with 2.5 mM glucose (Glc), the medium was switched to
basal medium (KRBH without glucose) for 5 min, after which the
collection of photon count data and perifusate was begun. After an
additional 10-min perifusion of basal medium, a 10-min stimulus with 2 mM DHA was initiated followed by 30 min with basal medium,
a second 10-min stimulation with 16 mM glucose, and a final
15-min of basal medium. Note that the kinetics and magnitude of DHA and
glucose stimulation are similar. B, glycerol
(Gly) stimulation. The protocol of panel A was
repeated with 2 mM glycerol replacing the 2 mM
DHA stimulation. Again, the kinetics and magnitude of glycerol and
glucose stimuli are similar. C, rotenone (ROT)
inhibition of glycerol stimulation. After a 10-min stimulation with 2 mM glycerol, 50 nM rotenone (an inhibitor of
NAD-linked substrate oxidation) rapidly decreased both mitochondrial
Ca2+ and insulin release. Each trace is representative of
3-5 experiments.
|
|
Combined with the dynamic measurements of mitochondrial membrane
potential (Fig. 4), these experiments define the following temporal
sequence. Approximately 3 min after fuel application, the mitochondrial
membrane becomes maximally hyperpolarized (Fig. 4, A and
B). Two min later (t = 5 min), mitochondrial
Ca2+ peaks, and an additional 2 min thereafter
(t = 7 min), insulin secretion reaches a maximum.
Mitochondrial membrane hyperpolarization therefore precedes the
elevation of mitochondrial matrix Ca2+ and insulin
secretion, suggesting that this event plays a primary role in the
regulation of fuel responsiveness.
 |
DISCUSSION |
By investigating the metabolic fates of glycerol, DHA, glucose,
and pyruvate, our data suggest that mitochondrial activation is the
common point of action of each of these fuels. Large increases of
glycolytic intermediates did not impact insulin secretion, whereas
mitochondrial membrane hyperpolarization strongly correlated with
the limitations of insulin output. Expression of E. coli glycerol kinase enables phosphorylation of DHA and glycerol with their
phosphorylated products lying on opposite sides of the glycerol phosphate shuttle. Very large alterations in the ratio of DHAP:glycerol phosphate (indicative of redox status) did not impact insulin secretion
as long as further mitochondrial metabolism was allowed. In contrast,
blocking the respiratory chain with rotenone inhibited insulin
secretion in response to any of the four fuels. Rotenone specifically
inhibits the respiratory chain at complex I (where NADH generated by
several dehydrogenase reactions is oxidized) while leaving the
remaining steps of the electron transport chain intact. This property
is particularly advantageous when understanding glycerol stimulation of
insulin secretion. Since cytosolic glycerol phosphate can directly
produce FADH2 in the mitochondria via the mitochondrial
FAD-linked glycerophosphate dehydrogenase, metabolism of glycerol can
provide input into the electron transport chain downstream of a complex
I block. Nonetheless, glycerol responsiveness in INS1-E cells requires
NAD-substrate oxidation as evident by the impairment of insulin
secretion by rotenone (Fig. 5C). This observation
demonstrates that the glycerophosphate shuttle alone cannot sustain
insulin secretion without an ability to provide electron input at
complex I and regenerate NAD+.
Although pyruvate is an effective stimulus in the INS1 cell line,
pyruvate-stimulated insulin secretion is not typically observed in
pancreatic islet preparations. This observation is the basis of
the pyruvate paradox, because pyruvate oxidation is observed in
such preparations but is not accompanied by insulin secretion (20, 21).
This has been partially addressed by the finding of low levels of
expression of MCT-1, a plasma membrane pyruvate transporter, in rat
islets as compared with the INS1 cell line (52). This report also
demonstrated that adenovirus-mediated expression of MCT-1 confers
pyruvate-stimulated insulin secretion in rat islets. Pyruvate oxidation
in islets in the absence of MCT-1 expression has been suggested to
occur in non-beta bells. In support of this idea, immunofluorescence
studies suggest that MCT-1 expression is concentrated at the periphery
of the rat islet where most of the non-beta cells reside (53). However,
the authors also report low levels of MCT-1 expression in non-beta
cells by immunoblot analysis, suggesting that further investigation of this issue will be required.
Nonetheless, the fact that pyruvate is an effective secretagogue in a
cell type that lacks gluconeogenic enzymes and has poor lipogenic
capacity suggests that mitochondrial metabolism of pyruvate is the
major means for generation of coupling factors. Consistent with this
idea, neither triose phosphates nor FBP increase during pyruvate
stimulation (Fig. 2, B and C), whereas
mitochondrial depolarization (Fig. 4D) is strongly induced
and correlates with insulin secretion (Fig. 1D). Pyruvate
has two immediate fates upon entering the mitochondria, decarboxylation
by pyruvate dehydrogenase to yield acetyl CoA and carboxylation by
pyruvate carboxylase to yield oxaloacetate. Pancreatic beta cells have
high pyruvate carboxylase activity as compared with other
non-gluconeogenic tissues (54, 55). One advantage of high pyruvate
carboxylase activity is the provision of tricarboxylic acid cycle
intermediates. Specifically, and increase in oxaloacetate facilitates
efficient entry of acetyl CoA into the tricarboxylic acid cycle and
provides substrate for the pyruvate malate and malate aspartate
shuttles. Likewise, citrate is utilized by the pyruvate citrate
shuttle, and
-ketoglutarate serves as substrate for glutamate
synthesis (40).
Pyruvate and triose fuels bypass the primary flux determining enzyme of
glycolysis, glucokinase, and thus reveal metabolic constraints beyond
this step. Other studies have demonstrated a similar observation by
reducing the control strength of glucokinase by overexpression of
glucokinase. With a mere 2.5-fold increase in glucokinase activity in
an INS clone engineered for inducible expression of glucokinase, the
rate of insulin secretion at 6 mM glucose increased from 43 to 84% of a 12 mM glucose challenge (56). However, the
maximal insulin output achieved at 12 mM glucose was not
enhanced by increased glucokinase activity. Similarly, a 20-fold
increase of glucokinase activity by adenoviral-mediated expression of
glucokinase in rat pancreatic islets only increased insulin output by
29%, again indicating factors downstream of glucokinase restrict
metabolism (57).
In this study, we suggest that the ultimate limitation of beta cell
metabolism is the formation of the proton gradient since the secretory
potency of each of the fuels used in this study converge on their
stimulatory effects on mitochondrial membrane potential. The proton
gradient in turn directly limits other metabolic steps including
pyruvate entry into the mitochondria (58) and the NAD+ regeneration
required for sustaining the activity of mitochondrial dehydrogenases.
The possibility that pyruvate entry becomes limited is supported by the
observation that triose secretagogues can increase pyruvate levels
above those observed from a glucose stimulus (Fig. 2D).
Bypassing NADH-oxidoreductase with either the excess glycerol phosphate
generated during a glycerol stimulus in GlpK-expressing INS1-E cells
(Fig. 4A) or methyl succinate (Fig. 4E) did not
further hyperpolarize the mitochondrial membrane. This observation
strongly suggests that complex I of the electron transport chain does
not in itself limit the formation of the proton gradient, but rather
the rate of the gradient formation exceeds the dissipation rate under
these conditions.
It must be clarified that although our results demonstrate a common
constraint in metabolism and fuel-stimulated insulin secretion, they do
not suggest that with the highest concentration of each fuel tested
here, the absolute limit of insulin output was obtained. Clearly,
potentiators such as fatty acids, incretin hormones, and phorbol esters
(59-61) can surpass the limits of a fuel-only stimulus, and this
observation is similarly demonstrated in this study (Fig.
1E). This implies that the efficacy of a fuel-only stimulus
is limited by mitochondrial metabolism and not by the innate secretory
capacity of the cell.
The mechanism underlying the limitations imposed by the mitochondrial
membrane potential is likely related to the thermodynamics of
generation of the proton gradient across the mitochondrial inner
membrane. NADH and FADH2 generated in the tricarboxylic acid cycle donate electrons to the electron transport chain, which in
turn supplies the energy to pump protons across the mitochondrial inner
membrane at three distinct sites (complexes I, III, and IV) to create a
gradient. The energy required to pump a proton across this gradient
increases as the pH difference between compartments increases. This
energy requirement is further increased because the internal surface of
the inner mitochondrial membrane becomes more negative than its
external surface as each proton is pumped out of the matrix. These two
factors cause the energy required for creating the proton gradient to
increase exponentially with each additional proton pumped out of
the mitochondrial matrix. Eventually the maximal proton gradient will
be reached when the energy required to pump protons exceeds the energy
provided by the reduction potential of NADH and FADH2, and
proton pumping will cease. The limitations of the formation of the
proton gradient therefore limit the production of mitochondrial
coupling factors such as ATP. In addition to ATP/ADP exchange, the
mitochondrial membrane potential drives the transport of other
metabolites between mitochondrial and cytosolic compartments. Again, of
particular interest is glutamate/aspartate exchange (62) given that
glucose-derived glutamate may act directly upon insulin secretion
(40).
The importance of generation of a proton gradient in secretion coupling
is further supported by data showing that inhibitors of the electron
transport chain and ATP generation or agents that dissipate the proton
gradient all impair insulin secretion. The uncoupling proteins
(UCP1-3) dissipate the energy of the protein gradient as heat rather
than ATP generation by facilitating proton transfer across the inner
mitochondrial membrane (63). Overexpression of UCP2 in normal rat
islets decreases ATP content (64) and inhibits GSIS (65). Induction of
UCP2 by chronic exposure of cells to fatty acids (66), feeding rodents
with a high fat diet (64), or the up-regulation of UCP2 found in
ob/ob mouse islets is accompanied in all cases with a defect
in fuel-stimulated secretion. Conversely, UCP2-deficient mice
UCP2 (
/
) demonstrate increased ATP production and
improved insulin secretion (67). The resulting ob/ob,
UCP2 (
/
) mice created from mating these two mouse
strains have partially restored glucose sensing, which again highlights the importance of a tight coupling of metabolism to the proton gradient, mitochondrial membrane potential, and ATP generation (66).
We propose that the formation of the mitochondrial proton gradient sets
the maximal limit of insulin secretion observed by the four fuels
studied here. The implication of this hypothesis is that strategies
designed to improve the maximal insulin output will be restricted by
this biophysical limitation. Considering that increased insulin output
can compensate for insulin resistance in some forms of diabetes,
determinants of maximal insulin output may be important targets for new
therapeutic approaches. Successful beta cell adaptation to insulin
resistance includes increasing beta cell mass via hypertrophy and/or
hyperplasia and improved responsiveness (68). Improved fuel
responsiveness is generally restricted to an increase in the
sensitivity of the fuel rather than improved maximal output. Therefore,
strategies that act upon the targets of potentiators and improve the
energy conversion from the mitochondrial proton gradient are most
likely to improve beta cell performance.
 |
ACKNOWLEDGEMENTS |
We thank D. Nappey and O. Dupont for
expert technical assistance and Dr. P. Maechler for stimulating
discussion. We owe a special thanks to Dr. J. Denis McGarry for
instigating our glycerol kinase overexpression studies. His mentorship
(to P. A. A. and C. B. N.) and scientific
excellence will be remembered and cherished.
 |
FOOTNOTES |
*
This study was supported by Grant 32-49755.96 from the Swiss
National Science Foundation (to C. B. W.) and by a European Union Network Grant (through the Swiss Federal Office for Education and
Science).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed. Tel.: 41-22-702-5554;
Fax: 41-22-702-5543; E-mail: Peter.Antinozzi@clocs.com.
Published, JBC Papers in Press, January 30, 2002, DOI 10.1074/jbc.M108462200
 |
ABBREVIATIONS |
The abbreviations used are:
GSIS, glucose stimulated insulin secretion;
Ad-GlpK, adenoviral-mediated
glycerol kinase;
Ad-CAG-mAeq, adenoviral-mediated mitochondrial
targeted aequorin;
DHA, dihydroxyacetone;
DHAP, dihydroxyacetone
phosphate;
GAP glyceraldehyde phosphate, FBP, fructose
1,6-bisphosphate;
PMA, phorbol 12-myristate 13-acetate;
KRBH, Krebs-Ringer bicarbonate buffer;
FCCP, carbonyl cyanide
p-trifluoromethoxyphenylhydrazone.
 |
REFERENCES |
| 1.
|
Newgard, C. B.,
and McGarry, J. D.
(1995)
Annu. Rev. Biochem.
64,
689-719[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Panten, U.,
Schwanstecher, M.,
Wallasch, A.,
and Lenzen, S.
(1988)
Naunyn-Schmiedeberg's Arch. Pharmacol.
338,
459-462[Medline]
[Order article via Infotrieve]
|
| 3.
|
Detimary, P.,
Van den Berghe, G.,
and Henquin, J. C.
(1996)
J. Biol. Chem.
271,
20559-20565[Abstract/Free Full Text]
|
| 4.
|
Henquin, J. C.
(2000)
Diabetes
49,
1751-1760[Abstract]
|
| 5.
|
MacDonald, M. J.
(1982)
Arch. Biochem. Biophys.
213,
643-649[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
MacDonald, M. J.
(1995)
J. Biol. Chem.
270,
20051-20058[Abstract/Free Full Text]
|
| 7.
|
Malaisse, W. J.,
Malaisse-Lagae, F.,
and Sener, A.
(1982)
Endocrinology
111,
392-397[Abstract]
|
| 8.
|
Giroix, M. H.,
Baetens, D.,
Rasschaert, J.,
Leclercq-Meyer, V.,
Sener, A.,
Portha, B.,
and Malaisse, W. J.
(1992)
Endocrinology
130,
2634-2640[Abstract]
|
| 9.
|
Sener, A.,
and Malaisse, W. J.
(1992)
J. Biol. Chem.
267,
13251-13256[Abstract/Free Full Text]
|
| 10.
|
MacDonald, M. J.
(1981)
J. Biol. Chem.
256,
8287-8290[Abstract/Free Full Text]
|
| 11.
|
Mertz, R. J.,
Worley, J. F.,
Spencer, B.,
Johnson, J. H.,
and Dukes, I. D.
(1996)
J. Biol. Chem.
271,
4838-4845[Abstract/Free Full Text]
|
| 12.
|
Eto, K.,
Tsubamoto, Y.,
Terauchi, Y.,
Sugiyama, T.,
Kishimoto, T.,
Takahashi, N.,
Yamauchi, N.,
Kubota, N.,
Murayama, S.,
Aizawa, T.,
Akanuma, Y.,
Aizawa, S.,
Kasai, H.,
Yazaki, Y.,
and Kadowaki, T.
(1999)
Science
283,
981[Abstract/Free Full Text]
|
| 13.
|
Eto, K.,
Suga, S.,
Wakui, M.,
Tsubamoto, Y.,
Terauchi, Y.,
Taka, J.,
Aizawa, S.,
Noda, M.,
Kimura, S.,
Kasai, H.,
and Kadowaki, T.
(1999)
J. Biol. Chem.
274,
25386-25392[Abstract/Free Full Text]
|
| 14.
|
Malaisse, W. J.,
Hutton, J. C.,
Kawazu, S.,
Herchuelz, A.,
Valverde, I.,
and Sener, A.
(1979)
Diabetologia
16,
331-341[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
MacDonald, M. J.,
and Fahien, L. A.
(1990)
Arch. Biochem. Biophys.
279,
104-108[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Silva, J. P.,
Kohler, M.,
Graff, C.,
Oldfors, A.,
Magnuson, M. A.,
Berggren, P. O.,
and Larsson, N. G.
(2000)
Nat. Genet.
26,
336-340[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Rotig, A.,
Bonnefont, J. P.,
and Munnich, A.
(1996)
Diabetes Metab.
22,
291-298[Medline]
[Order article via Infotrieve]
|
| 18.
|
Soejima, A.,
Inoue, K.,
Takai, D.,
Kaneko, M.,
Ishihara, H.,
Oka, Y.,
and Hayashi, J. I.
(1996)
J. Biol. Chem.
271,
26194-26199[Abstract/Free Full Text]
|
| 19.
|
Kennedy, E. D.,
Maechler, P.,
and Wollheim, C. B.
(1998)
Diabetes
47,
374-380[Abstract]
|
| 20.
|
Sener, A.,
Kawazu, S.,
Hutton, J. C.,
Boschero, A. C.,
Devis, G.,
Somers, G.,
Herchuelz, A.,
and Malaisse, W. J.
(1978)
Biochem. J.
176,
217-232[Medline]
[Order article via Infotrieve]
|
| 21.
|
Zawalich, W. S.,
and Zawalich, K. C.
(1997)
J. Biol. Chem.
272,
3527-3531[Abstract/Free Full Text]
|
| 22.
|
Ashcroft, S. J.,
Weerasinghe, L. C.,
and Randle, P. J.
(1973)
Biochem. J.
132,
223-231[Medline]
[Order article via Infotrieve]
|
| 23.
|
Alcazar, O.,
Gine, E.,
Qiu-Yue, Z.,
and Tamarit-Rodriguez, J.
(1995)
Biochem. J.
310,
215-220[Medline]
[Order article via Infotrieve]
|
| 24.
|
Malaisse, W. J.,
Herchuelz, A.,
Levy, J.,
Sener, A.,
Pipeleers, D. G.,
Devis, G.,
Somers, G.,
and Obberghen, E. V.
(1975)
Mol. Cell. Endocrinol.
4,
1-12[Medline]
[Order article via Infotrieve]
|
| 25.
|
MacDonald, M. J.
(1989)
Arch. Biochem. Biophys.
270,
15-22[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Elliot, A. C.,
Trebilock, R.,
Yates, P.,
and Best, L.
(1993)
Eur. J. Biochem.
213,
359-365[Medline]
[Order article via Infotrieve]
|
| 27.
|
Arkhammar, P.,
Berggren, P. O.,
and Rorsman, P.
(1986)
Biosci. Rep.
6,
355-361[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Juntli-Berggren, L.,
Rorsman, P.,
Siffert, W.,
and Berggren, P. O.
(1992)
Biochem. J.
287,
59-66[Medline]
[Order article via Infotrieve]
|
| 29.
|
Jijkali, H.,
Nadi, A. B.,
Cook, L.,
Best, L.,
Sener, A.,
and Malaisse, W. J.
(1996)
Arch. Biochem. Biophys.
355,
245-257
|
| 30.
|
Lembert, N.,
Joos, H. C.,
Idahl, L.,
Ammon, H. P. T.,
and Wahl, M. A.
(2001)
Biochem. J.
35,
345-350
|
| 31.
|
Noel, R. J.,
Antinozzi, P. A.,
McGarry, J. D.,
and Newgard, C. B.
(1997)
J. Biol. Chem.
172,
18621-18627
|
| 32.
|
Skelly, R. H.,
Wicksteed, B.,
Antinozzi, P. A.,
and Rhodes, C. J.
(2001)
Diabetes
50,
1791-1798[Abstract/Free Full Text]
|
| 33.
|
Asfari, M.,
Janjic, D.,
Meda, P., Li, G.,
Halban, P. A.,
and Wollheim, C. B.
(1992)
Endocrinology
130,
167-178[Abstract]
|
| 34.
|
Bergmeyer, H. U.
(1974)
Methods of Enzymatic Analysis
, Verlag Chemie GmbH, Weinheim, Germany
|
| 35.
|
Antinozzi, P. A.,
Segall, L.,
Prentki, M.,
McGarry, J. D.,
and Newgard, C. B.
(1998)
J. Biol. Chem.
273,
16146-16154[Abstract/Free Full Text]
|
| 36.
|
Wieland, O.,
and Suyter, M.
(1957)
Biochem. Z.
329,
320[Medline]
[Order article via Infotrieve]
|
| 37.
|
Miyake, S.,
Makimura, M.,
Kanegae, Y.,
Harada, S.,
Sato, Y.,
Takamori, K.,
Tokuda, C.,
and Saito, I.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
1320-1324[Abstract/Free Full Text]
|
| 38.
|
Kennedy, E. D.,
Rizzuto, R.,
Theler, J. M.,
Pralong, W. F.,
Bastianutto, C.,
Pozzan, T.,
and Wollheim, C. B.
(1996)
J. Clin. Invest.
98,
2524-2538[Medline]
[Order article via Infotrieve]
|
| 39.
|
Janjic, D.,
Maechler, P.,
Sekine, N.,
Bartley, C.,
Annen, A.,
and Wollheim, C. B.
(1999)
Biochem. Pharmacol.
57,
639-648[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Maechler, P.,
and Wollheim, C. B.
(1999)
Nature
402,
685-689[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Maechler, P.,
Antinozzi, P. A.,
and Wollheim, C. B.
(2000)
IUBMB Life
50,
27-31[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Hayashi, S.,
and Lin, E. C. C.
(1967)
J. Biol. Chem.
242,
1030-1035[Abstract/Free Full Text]
|
| 43.
|
Matschinsky, F. M.,
Glaser, B.,
and Magnuson, M. A.
(1998)
Diabetes
47,
307-315[Abstract]
|
| 44.
|
McGinnis, J.,
and DeVellis, J.
(1974)
Biochim. Biophys. Acta
364,
17-27[Medline]
[Order article via Infotrieve]
|
| 45.
|
Garrib, A.,
and McMurray, W. C.
(1986)
J. Biol. Chem.
261,
8042-8048[Abstract/Free Full Text]
|
| 46.
|
Rutter, G. A.,
Pralong, W. F.,
and Wollheim, C. B.
(1992)
Biochim. Biophys. Acta
1175,
107-113[Medline]
[Order article via Infotrieve]
|
| 47.
|
MacDonald, M. J.,
McKenzie, D. I.,
Walker, T. M.,
and Kaysen, J. H.
(1992)
Horm. Metab. Res.
24,
158-160[Medline]
[Order article via Infotrieve]
|
| 48.
|
Meglasson, M. D.,
and Matschinsky, F. M.
(1986)
Diabetes Metab. Rev.
2,
163-214[Medline]
[Order article via Infotrieve]
|
| 49.
|
Berman, H. K.,
and Newgard, C. B.
(1998)
Biochemistry
37,
4543-4552[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Matschinsky, F. M.,
Ghosh, A. K.,
Meglasson, M. D.,
Prentki, M.,
June, V.,
and von Allman, D.
(1986)
J. Biol. Chem.
261,
14057-14061[Abstract/Free Full Text]
|
| 51.
|
Maechler, P.,
Kennedy, E. D.,
Pozzan, T.,
and Wollheim, C. B.
(1997)
EMBO J.
16,
3833-3841[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Ishihara, H.,
Wang, H.,
Drewes, L. R.,
and Wollheim, C. B.
(1999)
J. Clin. Invest.
104,
1621-1629[Medline]
[Order article via Infotrieve]
|
| 53.
|
Zhao, C.,
Wilson, M. C.,
Schuit, F.,
Halestrap, A. P.,
and Rutter, G. A.
(2001)
Diabetes
50,
361-366[Abstract/Free Full Text]
|
| 54.
|
Brun, T.,
Roche, E.,
Assimacopoulos-Jeannet, F.,
Corkey, B. E.,
Kim, K. H.,
and Prent |